CompoAtlas

Muscletech SX-7 Black Onyx Shatter

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Choline

Source : Bitartrate de choline

75 mgNot calculated
Choline

Source : Alfoscérate de choline

75 mgNot calculated
Adénosine 5'-(disodium triphosphate)

Source : Adénosine triphosphate disodium

Potency : 368 mg Adenosine triphosphate

400 mgNot calculated
Acide 2-aminoéthanesulfonique

Source : Taurine

1 gNot calculated
L-Citrulline

Source : Malate de citrulline

3 gNot calculated
7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione

Source : Théacrine

40 mgNot calculated

Non-medicinal ingredients

Saveur, Dioxyde de silicium, Acide DL-malique, Acide citrique, Sucralose, Acésulfame potassium, Maltodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Portion(s)1 Tous les jours

Uses authorised in Canada

Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps to delay muscle fatigue by increasing carnosine levels. Helps to temporarily increase thermogenesis and basal metabolic rate.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Iovate Health Sciences International Inc.
NPN or DIN-HM
80091027
Status
Active licence
Licence date
28 February 2019
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80091027

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Muscletech SX-7 Black Onyx Shatter”, https://compoatlas.com/en/supplements/canada/80091027-muscletech-sx-7-black-onyx-shatter, updated 28 February 2019.

Enter to analyse, Shift+Enter for a new line